HUP9901191A2 - Fájdalomcsillapító hatású anyagot termelő sejtvonal fájdalmak kezelésére - Google Patents
Fájdalomcsillapító hatású anyagot termelő sejtvonal fájdalmak kezeléséreInfo
- Publication number
- HUP9901191A2 HUP9901191A2 HU9901191A HUP9901191A HUP9901191A2 HU P9901191 A2 HUP9901191 A2 HU P9901191A2 HU 9901191 A HU9901191 A HU 9901191A HU P9901191 A HUP9901191 A HU P9901191A HU P9901191 A2 HUP9901191 A2 HU P9901191A2
- Authority
- HU
- Hungary
- Prior art keywords
- cell line
- treating pain
- line producing
- analgesic compounds
- pain
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000000202 analgesic effect Effects 0.000 title 1
- 241000131858 Siboglinidae Species 0.000 abstract 1
- 210000000576 arachnoid Anatomy 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 238000005538 encapsulation Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 238000009987 spinning Methods 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/70—Enkephalins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48191795A | 1995-06-07 | 1995-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP9901191A2 true HUP9901191A2 (hu) | 1999-08-30 |
Family
ID=23913905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9901191A HUP9901191A2 (hu) | 1995-06-07 | 1996-06-07 | Fájdalomcsillapító hatású anyagot termelő sejtvonal fájdalmak kezelésére |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0833935A1 (enExample) |
| JP (1) | JPH11507530A (enExample) |
| KR (1) | KR19990022414A (enExample) |
| CN (1) | CN1192246A (enExample) |
| AR (1) | AR004494A1 (enExample) |
| AU (1) | AU6263696A (enExample) |
| BR (1) | BR9608746A (enExample) |
| CA (1) | CA2223246A1 (enExample) |
| CZ (1) | CZ392497A3 (enExample) |
| EE (1) | EE9700326A (enExample) |
| HU (1) | HUP9901191A2 (enExample) |
| IL (1) | IL122415A0 (enExample) |
| IN (1) | IN181898B (enExample) |
| IS (1) | IS4628A (enExample) |
| NO (1) | NO975545L (enExample) |
| PL (1) | PL323867A1 (enExample) |
| SK (1) | SK167997A3 (enExample) |
| TR (1) | TR199701520T1 (enExample) |
| WO (1) | WO1996040959A1 (enExample) |
| ZA (1) | ZA964880B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001525168A (ja) * | 1997-11-28 | 2001-12-11 | メディカル リサーチ カウンシル | ベクター |
| AU6151899A (en) * | 1998-09-23 | 2000-04-10 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Methods of treating chronic pain |
| US6372489B1 (en) | 1998-10-27 | 2002-04-16 | Anticancer, Inc. | Method and model for hair pigmentation |
| WO2000024895A2 (en) * | 1998-10-27 | 2000-05-04 | Anticancer, Inc. | Method and model for hair pigmentation |
| US6903244B1 (en) | 1999-02-26 | 2005-06-07 | University Of Utah Research Foundation | Mice which are +/− or −/− for the elastin gene as models for vascular disease |
| AU2002952993A0 (en) | 2002-11-29 | 2002-12-12 | The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland | Therapeutic and diagnostic agents |
| CA2551189A1 (en) | 2003-12-24 | 2005-07-07 | The Walter And Eliza Hall Institute Of Medical Research | Therapeutic agents and uses therefor |
| NZ551828A (en) | 2004-05-12 | 2009-03-31 | Inst Medical W & E Hall | A method of cell isolating a homogenous population of mammary stem cells using specific cell surface marker proteins |
| EP1910535B1 (en) | 2005-06-24 | 2016-08-17 | The Walter And Eliza Hall Institute Of Medical Research | Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same |
| JP5558817B2 (ja) | 2006-07-18 | 2014-07-23 | ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション | 痛みの処置方法および鎮痛化合物のスクリーニング方法 |
| US8889173B2 (en) * | 2008-04-18 | 2014-11-18 | Warsaw Orthopedic, Inc. | Alpha adrenergic receptor agonists for treatment of pain and/or inflammation |
| JP6681826B2 (ja) | 2013-05-31 | 2020-04-15 | ザ ユニバーシティ オブ ユタ リサーチ ファウンデイション | コノトキシンペプチド、医薬組成物およびそれらの使用 |
| JP6877419B2 (ja) | 2015-10-27 | 2021-05-26 | ザ ユニバーシティー オブ クイーンズランド | 治療の方法およびそのために有用な剤 |
| CN107964047B (zh) * | 2017-12-18 | 2018-11-02 | 哈尔滨工业大学 | 基于内吗啡肽-1和神经降压素(8-13)的嵌合肽及其合成方法和应用 |
| CN112891337A (zh) * | 2021-03-26 | 2021-06-04 | 河北医科大学 | 高良姜素及其衍生物在制备预防和治疗神经系统疾病药物中的用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2178654T3 (es) * | 1993-08-12 | 2003-01-01 | Neurotech Sa | Capsulas biocompatibles inmonoaisladoras que contienen celulas geneticamente alteradas para el suministro de moleculas biologicamente activas. |
-
1996
- 1996-06-05 IN IN1039CA1996 patent/IN181898B/en unknown
- 1996-06-06 AR ARP960102993A patent/AR004494A1/es unknown
- 1996-06-07 SK SK1679-97A patent/SK167997A3/sk unknown
- 1996-06-07 KR KR1019970708894A patent/KR19990022414A/ko not_active Withdrawn
- 1996-06-07 AU AU62636/96A patent/AU6263696A/en not_active Abandoned
- 1996-06-07 JP JP9501908A patent/JPH11507530A/ja active Pending
- 1996-06-07 PL PL96323867A patent/PL323867A1/xx unknown
- 1996-06-07 CZ CZ973924A patent/CZ392497A3/cs unknown
- 1996-06-07 TR TR97/01520T patent/TR199701520T1/xx unknown
- 1996-06-07 CA CA002223246A patent/CA2223246A1/en not_active Abandoned
- 1996-06-07 IL IL12241596A patent/IL122415A0/xx unknown
- 1996-06-07 CN CN96195750A patent/CN1192246A/zh active Pending
- 1996-06-07 EP EP96921403A patent/EP0833935A1/en not_active Withdrawn
- 1996-06-07 HU HU9901191A patent/HUP9901191A2/hu unknown
- 1996-06-07 EE EE9700326A patent/EE9700326A/xx unknown
- 1996-06-07 BR BR9608746A patent/BR9608746A/pt unknown
- 1996-06-07 WO PCT/US1996/009629 patent/WO1996040959A1/en not_active Ceased
- 1996-06-07 ZA ZA964880A patent/ZA964880B/xx unknown
-
1997
- 1997-12-02 NO NO975545A patent/NO975545L/no unknown
- 1997-12-04 IS IS4628A patent/IS4628A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO975545D0 (no) | 1997-12-02 |
| AU6263696A (en) | 1996-12-30 |
| PL323867A1 (en) | 1998-04-27 |
| NO975545L (no) | 1998-02-04 |
| BR9608746A (pt) | 1999-05-11 |
| TR199701520T1 (xx) | 1998-04-21 |
| CZ392497A3 (cs) | 1998-12-16 |
| IN181898B (enExample) | 1998-10-24 |
| SK167997A3 (en) | 1998-05-06 |
| IL122415A0 (en) | 1998-06-15 |
| AR004494A1 (es) | 1998-12-16 |
| ZA964880B (en) | 1997-01-07 |
| WO1996040959A1 (en) | 1996-12-19 |
| EE9700326A (et) | 1998-06-15 |
| CN1192246A (zh) | 1998-09-02 |
| CA2223246A1 (en) | 1996-12-19 |
| IS4628A (is) | 1997-12-04 |
| JPH11507530A (ja) | 1999-07-06 |
| EP0833935A1 (en) | 1998-04-08 |
| KR19990022414A (ko) | 1999-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE237285T1 (de) | Medizinisches implantat | |
| CY1112260T1 (el) | Σκευασματα υδροκωδονης ελεγχομενης απελευθερωσης | |
| IS4083A (is) | Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja | |
| HUP9700322A2 (hu) | Hosszabb lokálanesztézist biztosító készítmény és módszerek | |
| JO1613B1 (en) | Derivatives of n - (3-hydroxy-4-piperidnil) dihydrobenzofuran, dihydro-2u-benzopyran or dihydro-benzodoxine) carboxymide | |
| HUP9800794A2 (hu) | (S)-oxi-butinin és (S)-dezetil-oxi-butinin alkalmazása vizelet inkontinencia kezelésére alkalmazható gyógyszerkészítmények előállítására és a vegyületek előállítása | |
| ATE239474T1 (de) | Verwendung von levobupivacain | |
| FI98136B (fi) | Kudosolosuhteissa hajoava materiaali ja menetelmä sen valmistamiseksi | |
| ATE238049T1 (de) | Verwendung von kreatinsubstanzen zur behandlung von knochen- und knorpelzellen und geweben | |
| ATE220400T1 (de) | Trizyklische verbindungen zur behandlung von zellproliferativen störungen | |
| ATE316779T1 (de) | Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung | |
| BR9807916A (pt) | Conjunto de dispositivo biomédico, método para inibir substancialmente a reestenose em um vaso sanguìneo de um paciente, método para fabricar um conjunto de dispositivo biomédico. | |
| NZ330944A (en) | Peptide derivatives | |
| DE69227583D1 (de) | Arylmorpholine, herstellung und verwendung | |
| DE69426530D1 (de) | Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz | |
| PT1147105E (pt) | Derivado de piridil-4h-1,2,4-oxadiazina opticamente activo e sua utilizacao no tratamento de doencas vasculares | |
| ATE321045T1 (de) | Methoden und zusammensetzungen zur behandlung von schmerzen | |
| TR199801184T2 (xx) | Analjezik tesirli yeni bile�ikler. | |
| ATE331523T1 (de) | Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion | |
| DE69434002D1 (de) | 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis | |
| PT795008E (pt) | Linhas de celulas de condrocitos hipertroficos humanos | |
| UA9740A (uk) | Спосіб гармонізації біологічних ритмів людини | |
| UA22223A (uk) | Спосіб лікуваhhя захворюваhь оргаhа зору | |
| DE69625819D1 (de) | Die verwendung von ondansetron zur herstellung eines medikamentes zur behandlung von tremor | |
| UA29186A (uk) | Спосіб лікування постменопаузального остеопорозу |